Clinical review: Myocardial depression in sepsis and septic shock

AUTOR(ES)

Court, Olivier

FONTE

BioMed Central

RESUMO

Myocardial dysfunction frequently accompanies severe sepsis and septic shock. Whereas myocardial depression was previously considered a preterminal event, it is now clear that cardiac dysfunction as evidenced by biventricular dilatation and reduced ejection fraction is present in most patients with severe sepsis and septic shock. Myocardial depression exists despite a fluid resuscitation-dependent hyperdynamic state that typically persists in septic shock patients until death or recovery. Cardiac function usually recovers within 7–10 days in survivors. Myocardial dysfunction does not appear to be due to myocardial hypoperfusion but due to circulating depressant factors, including the cytokines tumor necrosis factor alpha and IL-1β. At a cellular level, reduced myocardial contractility seems to be induced by both nitric oxide-dependent and nitric oxide-independent mechanisms. The present paper reviews both the clinical manifestations and the molecular/cellular mechanisms of sepsis-induced myocardial depression.

Documentos Relacionados

• Clinical review: Corticotherapy in sepsis
• Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock – does the dose matter?
• Clinical review: Hypertonic saline resuscitation in sepsis
• Clinical review: Influence of vasoactive and other therapies on intestinal and hepatic circulations in patients with septic shock
• Clinical review: Extracorporeal blood purification in severe sepsis